ChiRex (CHRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ChiRex (CHRX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen Ettorre who wrote (98)	1/28/1998 11:19:00 AM
From: Haseltine	Read Replies (1) of 130

Try Chemical Week chemweek.com which has an article in the Jan 16 issue with abstract: A surge in the life sciences last year boosted the $60-billion fine chemicals market, where 5% growth is still largely driven by pharmaceutical and agchem outsourcing. Larger companies with biotech and chiral expertise are vying for lead positions. There is also an article on outsourcing by pharma companies in the current issue of Chemical & Engineering News. Unfortunately, I can't find an electronic version posted yet. But it says basically the same thing as the Chemical Week article says:-- "Growth in custome chemicals--the business of fine chemicals firms producing chemicals to special order for other companies--has been accelerating during the past year..." There is a minor mention of ChiRex later in the article. Hope this helps. Good luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next